{"name":"Faraday Pharmaceuticals, Inc.","slug":"faraday-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxOSHZoVG9KTk1PeDhha3F6eXZLalN1bmFZMy1wX2tPRm5NYWJ2aVQ3RE5zMGFvWnpiaGNqNDdsUXFtODN3SmE1THROdU5PV0FJN3ZFZGVzeHdXRDZSZzRfX2tZcXhHZHVaS0paZkFxLVJJaXdCeXpDU1E4cGV4eGYwVFJ1cFBIX3E5T0YtRElZNF9GZTBWY25RX0hSSEw0Y25DUllCRVJQTjNNRGtLMTV6amFWNTJvcTJDRExiZnJCbks2bTBlLU5UOHI3N0MzanJuenlUa3l4S2FOOTJWazVsWVNOeVpsOWU0X3V0LWRzNFdJUTlLcUhNdTNtb2QtVnFjZExMXzdJZVpxUkM3VXFLc3lKX1hVY0l1V1lZZjcxUXg5XzhDcGliN0EyWUloTGpma1ZzSFB4cU9HTmJnRXlNMFZn?oc=5","date":"2026-03-02","type":"pipeline","source":"globenewswire.com","summary":"Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight - globenewswire.com","headline":"Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPYWNMMHhMajJ5UkdBVEdfSkxQaFBQc25acFlwQy03cTB6V21vUEJkZDdiaGZHTHlyemxTUXNkRTNvNFZOZENXTmZoRzhCMlZfYzlfbGVOUDZ4QXgxQ18tYkVzRmNkV2ZpMjRYT3M1OFJmczh6dHl2QVY5YUxud3NxTzUtWk4wU2xJRHc?oc=5","date":"2025-11-25","type":"trial","source":"finance.yahoo.com","summary":"Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight - finance.yahoo.com","headline":"Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveIn","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxONWpINWxnOFJjcG9LdzRUbGFULXJRcG56MHRwVVNETnNOUzJ0aU1FanAzZFRQcVRVNmZ3bXZTRG5pT2k5cjVhNDJfMWI0NUFHbU82dVZrYXc2ZzBmTklqamFzQWZETUZUWE5ELTEteFMzaG9DT3lidG1SWms1blZyVkZ5amQxVXQ2dVRCQm1HNDBhV2Y5Szg5cXJKb3AxcnM0MHVNZDQwUmtrcHQ1eFJIR3BVakhIT00?oc=5","date":"2025-11-16","type":"pipeline","source":"Stock Titan","summary":"Qualigen (NASDAQ: QLGN) to Rebrand as AIxCrypto, Launch AI × Web3 Strategy Nov. 20 - Stock Titan","headline":"Qualigen (NASDAQ: QLGN) to Rebrand as AIxCrypto, Launch AI × Web3 Strategy Nov. 20","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQSklvWUJkWjdUUm9jNHdVMS11YTRyNUxRSUlzSTBOVHc1Y2R4S2R3T1ZpSUk5YTdVY29kMGNXdUh6Z3BydlpmMEdTWGJTX2lCSzFGOVJrVk5LQ2ptVlA1dlNmTTdXZjBFcGVPZTlIWUlrSmRZT3NqTngyWnMwRE9zZmhMakZMTTdnbi1YZkR4dEtpLTRCMk1Ga0JLZGlxZWUzakduVUpKcjFnUXdycjRWM0JDbnBLU0E4Y3VmQ0VSbVRDdnNmTmVaWW9zamdpRm9QYjZrWDNsemx2REJKX183NTdRYmpsV1ltUkRocDJ4LS1zelBleGk3YWozbkRlSEp1d2Yzc1pVVEpLUGxsbnc?oc=5","date":"2025-09-30","type":"pipeline","source":"Investing News Network","summary":"Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto - Investing News Network","headline":"Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUjNnSVpMZWZCcFVic2FxS0pHaWxsZk9XdVZvVnFNX1hMaEhkMm1Vem8yTmRWMlBQYlpQV1FNUmVURVBwYlJJTmxTN1ItaDBCYzI1MmpwbHlJbHZQa0xmZjZVMjFka3ZTQklObzdOZkt0ZmdWSl9aejIwZXUxdDR3OFAxbkZxbGJGc2JOZUx6NVdjTHNicUwxY19EOEZxbC1lRGo1UGZyaUVVSG9NN1l3WWNuZGc3RkNYeTNj?oc=5","date":"2025-09-30","type":"deal","source":"Stock Titan","summary":"$41M Crypto Transformation: Qualigen Partners with EV Giant Faraday Future for Web3 Evolution to CXC10 - Stock Titan","headline":"$41M Crypto Transformation: Qualigen Partners with EV Giant Faraday Future for Web3 Evolution to CXC10","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPS25faHlwNHRtYWU0RG1TT0FRUU9IeEZkNlVvYkx4bWJkRzNHSFJMU2lLeW1uazVRRlJBcGZRUzBaUkNFMURLOTVUUmkyX1F6OWpDcXpMcEdYYUI3TERCUnU4VHpUOUh5MW1MeTVHN2JXQ0FSelRfZGNXRFluVXhval9OcXlEZzZYTWRFU1Bad2QxRXdaOWFsZ0RHSXgxQjdEUUlGZFR4NlJmbWZrb2xKeXZTb3ZfUnZIT3hPZ3Fqa0hhOUZWZ1dWeElxY1hNWmhhV0JQbE43Q3NHV1VrSXZpMFlZQ1VVRlZHbGIyNXBCV3IxTjJpVW1TWU5pdU9lTFpfRDJldkd0U3FseExXb25BNHRLaTJFZHdfQ0FXeHY2bTVkNkE?oc=5","date":"2025-09-30","type":"trial","source":"globenewswire.com","summary":"Atrial Fibrillation Clinical Trials & Pipeline Overview: - globenewswire.com","headline":"Atrial Fibrillation Clinical Trials & Pipeline Overview:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNWdPMm5jNVp4S0RDak5kRlBaRHp2ZFNJLWtmUTUxY3JTTVVLYjB3eWZSc1pGaU9DZFZBUnM3NFZwUWNhTmtMdEhWZDUzMnJnRnR0X29EWUJ5c3dpUXRmcGdDWkJydklDRWtLRWdvZXk2RHJ1Tkl2M1hqaVY3VEVLZno5VUV1emo0TjB3UVp5bm9qVzVzRS1zNzdMYjl3RTZERHlmRGU1SHdiSFB3ME1kaUxGdnlRQjZuRWdBbHdtbTM?oc=5","date":"2025-09-21","type":"pipeline","source":"Faraday Future","summary":"Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines","headline":"Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) Durin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOX0tWV1VaVnlYcXVwVnNxa1o0cDZ6eHQwMDR6VUUzTE9UdlFPVVhKMkFxRTNDUTA4bWo5UnFid0hLaHh2bVpDaGJvbHFTakpsSTF4TUFTSEkwOF9EV215M0d6REs3clN6UHQwZ0Q2bWtxM3Y0VkhSRUxtYVoxbEFweUg3WnYweGNmenkyM21jeGNhcFpQcm1BOWxnNF9LeTNyaFNtZDRFWWFKRUNXbk1hMnFJYkZuWHl5Zk1fSERRcXBoWnpfVFBDR2M1dVNrXy1IMkdzcGFtdzdvWGdWSnY2M0tHWWo5WFVwVG9PZjRwWldZbWt6aFFHUVlVek0yWHBCZUV2UHpmcEI5N0syUXRyT1A2ckpOdmc?oc=5","date":"2025-08-07","type":"trial","source":"globenewswire.com","summary":"Cancer Cachexia Clinical Trial Pipeline Shows Potential - globenewswire.com","headline":"Cancer Cachexia Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQTGNjSHNvSG43RDVXd2V2bWt1MWM0cnFuTmV0bW45US1yb2R6c1d5OVZtWmRVODgxV2Q1c25CMDFFaE5XOHJrem53NjhBRXBQMVpKU0psa2VqU0MzYnhSdFlhTkFzRjNaZDhFWjVDYTlGTzVCSnBjZks3b2FjQlUtOXRwZmJWTHZyMUFrSWVwVG5rOW9WVEtnYW8zel9iTE8xcE85NWpHdGRMdTFHSWpCOGhYdkZWZGhJanlyNHBhcUx3RWpQZTN1bWYwNzJGUzRGSmpHd2k4dHo0MzdvR1pZblBjNzBBTG5scVZxWldJUQ?oc=5","date":"2025-01-15","type":"pipeline","source":"PR Newswire","summary":"Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight - PR Newswire","headline":"Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE80MWNoYVNtdWc0RklibGc0ZUFNbEJfd2kwNEZDWVk4ZC1EZmdIUFNEdmJfU0dDaVVLazlLd3ZXVGFEREx0VWpIOFdRNzRXdkFuYkozcnYzUEtfdjhTN0lLa2FadUVLNXB1MlE?oc=5","date":"2024-12-16","type":"pipeline","source":"Wiley Online Library","summary":"Relationship Between Left Ventricular Ejection Fraction and ICD‐10 Codes Among Patients Hospitalized With Heart Failure - Gluckman - 2024 - Clinical Cardiology - Wiley Online Library","headline":"Relationship Between Left Ventricular Ejection Fraction and ICD‐10 Codes Among Patients Hospitalized With Heart Failure ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2024-07-15","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBRNXI3dGFXbHFBS2hLcDdRVl9PRHRkNTRFODRyM2c2NXd2YnNBWWxSY043Mm5Fa1V0R0tMRnZPbVN4N2NMdjFfejBfOXVGRWI1bjh4QlUtVjdxTXVnZFY2Qg?oc=5","date":"2024-04-06","type":"pipeline","source":"JACC Journals","summary":"Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI - JACC Journals","headline":"Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}